Aquestive Therapeutics, Inc.
AQST
$2.87
$0.020.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 71.55M | 77.89M | 89.87M | 95.20M | 23.87M |
| Total Receivables | 7.34M | 9.68M | 6.00M | 8.32M | 8.47M |
| Inventory | 6.04M | 7.02M | 6.97M | 7.73M | 6.77M |
| Prepaid Expenses | 3.29M | 1.97M | 1.18M | 2.12M | 1.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 88.22M | 96.57M | 104.01M | 113.38M | 40.97M |
|
|
|||||
| Total Current Assets | 88.22M | 96.57M | 104.01M | 113.38M | 40.97M |
| Net Property, Plant & Equipment | 8.98M | 9.16M | 9.36M | 9.49M | 9.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 0.00 | 0.00 | 1.24M | 1.28M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.22M | 4.23M | 4.24M | 5.42M | 5.44M |
| Total Assets | 101.42M | 109.96M | 117.61M | 129.52M | 57.42M |
|
|
|||||
| Total Accounts Payable | 10.29M | 7.57M | 5.70M | 10.52M | 8.93M |
| Total Accrued Expenses | 5.99M | 5.03M | 5.67M | 4.64M | 6.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 536.00K | 507.00K | 479.00K | 437.00K | 412.00K |
| Total Finance Division Other Current Liabilities | 2.05M | 2.05M | 2.05M | 2.46M | 2.47M |
| Total Other Current Liabilities | 2.05M | 2.05M | 2.05M | 2.46M | 2.47M |
| Total Current Liabilities | 18.87M | 15.15M | 13.90M | 18.06M | 18.31M |
|
|
|||||
| Total Current Liabilities | 18.87M | 15.15M | 13.90M | 18.06M | 18.31M |
| Long-Term Debt | 32.35M | 31.10M | 29.85M | 28.59M | 27.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.11M | 5.26M | 5.40M | 5.45M | 5.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 105.25M | 103.86M | 103.95M | 113.72M | 112.69M |
| Total Liabilities | 161.58M | 155.38M | 153.08M | 165.82M | 163.91M |
|
|
|||||
| Common Stock & APIC | 303.06M | 300.74M | 299.17M | 295.60M | 212.59M |
| Retained Earnings | -363.21M | -346.16M | -334.65M | -331.91M | -319.08M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -60.16M | -45.42M | -35.48M | -36.30M | -106.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -60.16M | -45.42M | -35.48M | -36.30M | -106.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -60.16M | -45.42M | -35.48M | -36.30M | -106.49M |
|
|
|||||